Mariangela Di Bella

7PUBLICATIONS
22CO-AUTHORS
Predictive and prognostic markersInnate immunityGene and molecular therapyMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 10, 2026
Immune-Based Biomarkers as Predictors of Mortality in ECMO Therapy for Severe COVID-19 ARDS: Insights from a Retrospective Study.

Rosalia Busà, Giovanna Panarello, Alessia Gallo

|Dec 11, 2022
Long-Term Effectiveness of BNT162b2 Pfizer-BioNTech mRNA-Based Vaccine on B Cell Compartment: Efficient Recall of SARS-CoV-2-Specific Memory B Cells.

Rosalia Busà, Monica Miele, Maria Concetta Sorrentino

|Oct 27, 2022
Immune Response after the Fourth Dose of SARS-CoV-2 mRNA Vaccine Compared to Natural Infection in Three Doses' Vaccinated Solid Organ Transplant Recipients.

Rosalia Busà, Giovanna Russelli, Monica Miele

|Aug 26, 2022
Analysis of the Specific Immune Response after the Third Dose of mRNA COVID-19 Vaccines in Organ Transplant Recipients: Possible Spike-S1 Reactive IgA Signature in Protection from SARS-CoV-2 Infection.

Monica Miele, Rosalia Busà, Giovanna Russelli

|Apr 03, 2021
Successful Use of Heterologous CMV-Reactive T Lymphocyte to Treat Severe Refractory Cytomegalovirus (CMV) Infection in a Liver Transplanted Patient: Correlation of the Host Antiviral Immune Reconstitution with CMV Viral Load and CMV miRNome.

Monica Miele, Alessia Gallo, Mariangela Di Bella

|Mar 06, 2021
Extracellular Vesicle-Derived microRNAs of Human Wharton's Jelly Mesenchymal Stromal Cells May Activate Endogenous VEGF-A to Promote Angiogenesis.

Cinzia Maria Chinnici, Gioacchin Iannolo, Ettore Cittadini

Pageof 2

Frequent Collaborators

6 joint publications

Pier Giulio Conaldi

5 joint publications

Matteo Bulati

4 joint publications

Rosalia Busà

4 joint publications

Monica Miele